Literature DB >> 25533158

Intralesional bleomycin sclerotherapy of lymphangioma: partial response to treatment.

Ane Maria Kunrath Simões Pires1, Clarissa Reinehr, Flávia Boff, Fernanda Luca Nazar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25533158     DOI： 10.1097/DSS.0000000000000237

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  2 in total

1.  Bleomycin Sclerotherapy in Lymphangiomas of Head and Neck: Prospective Study of 8 Cases.

Authors:  Prateek Kumar Porwal; K P Dubey; Amit Morey; Harshita Singh; S Pooja; Alokendu Bose
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-01-08

2.  Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes.

Authors:  Tarjani Vivek Dave; Bejjanki Kavya Madhuri; Srujana Laghmisetty; Devjyoti Tripathy; Swathi Kaliki; Suryasnata Rath; Samir Mohapatra; Akruti Desai; Anasua Ganguly Kapoor
Journal:  Eye (Lond)       Date:  2021-04-20       Impact factor: 3.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.